Please login to the form below

Not currently logged in
Email:
Password:

Britannia promotes Robert Wood

He takes up new marketing director role

Britannia_Robert_WoodBritannia Pharmaceuticals has promoted Robert Wood to marketing director, for international markets.

Wood was previously director partners, EMEA at Britannia and has 15 years experience in the life science and pharmaceutical industries.

Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

Britannia Pharmaceuticals has been working in Parkinson's disease for over thirty years and its APO-go product range is licensed in almost 40 countries.

Wood said: “I am delighted to be continuing to work with Britannia Pharmaceuticals in this new global role, particularly at this incredibly interesting time for the APO-go therapy.

“The initiation of clinical trials to increase the evidence base for both motor and non-motor effects of APO-go in Parkinson's disease and the development of new delivery devices, mean APO-go will provide an excellent treatment option for many more people with Parkinson's.”

3rd May 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics